Date:2/14/2013

may obtain for free on the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise.  We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Investor Contact: Sheree AronsonMedia Contact: Mike Drummond(949) 297-7043 (949) 297-7434 saronson@masimo.commdrummond@masimo.com Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care… by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, and SEDLine  are trademarks or registered trademarks of Masimo Corporation.

 

 

 MASIMO CORPORATION CONSOLIDATED BALANCE SHEETS (unaudited, in thousands) December 29,December 31,20122011ASSETSCurrent assetsCash and cash equivalents

$

71,554$

129,882Accounts receivable, net of allowance for doubtful accounts 67,91157,013Royalties receivable7,1307,102Inventories47,35845,944Prepaid expenses6,5076,424Prepaid income taxes2,0802,986Deferred tax assets12,91111,576Other current assets3,8962,008Total current assets219,347262,935Deferred cost of goods sold52,10351,679Property and equipment, net23,92415,239Intangible assets, net27,36311,393Goodwill22,824448Deferred tax assets22,36316,766O
'/>"/>

SOURCE Masimo Corporation Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. Masimo Announces Adoption of Stock Repurchase Program
2. Masimo to Report Fourth Quarter and Full Year 2012 Financial Results after Market Close on Thursday, February 14
3. Masimo Showcases Advanced, Noninvasive Patient Monitoring Technologies at Arab Health
4. Masimo Reports Third Quarter 2012 Financial Results; Board Declares Special Cash Dividend of $1.00 per Share
5. Masimo to Present at Lazard Capital Markets 9th Annual Healthcare Conference
6. Kennedy Health System Renews System-Wide Pulse Oximetry Contract with Masimo
7. Masimo Reschedules Release of Third Quarter 2012 Financial Results and Associated Conference Call to Thursday, November 1st Due to Hurricane Sandy
8. Inova Health System Re-Ups System-wide Pulse Oximetry Contract with Masimo
9. Masimo to Host Investor Day on September 20
10. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Masimo Corporation in Connection with Executive Compensation
11. Masimos Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery